Home / Health / Hidden Dangers of Weight-Loss & Acid Reflux Meds
Hidden Dangers of Weight-Loss & Acid Reflux Meds
30 Oct
Summary
- Millions of Brits take GLP-1 or PPI drugs.
- Neurological emergency linked to GLP-1 medications.
- Combined use of GLP-1 and PPI drugs increases risk.
A doctor has alerted millions of individuals in the UK to potential health risks associated with commonly prescribed medications. The concern specifically targets GLP-1 drugs, used for weight loss, and proton pump inhibitors (PPIs), often taken for acid reflux.
Research suggests that GLP-1 medications may increase the risk of Wernicke Encephalopathy, a severe neurological emergency caused by thiamine deficiency. This condition, characterized by symptoms like fatigue and confusion, can develop quickly due to reduced food intake.
Furthermore, Metformin, a diabetes drug, is known to cause vitamin B12 deficiency, while PPIs like Omeprazole can lead to multiple nutrient deficiencies. The combination of GLP-1 and PPI medications is identified as particularly high-risk due to increased chances of these deficiencies.
